A company developing cutting-edge technology which can detect drug use through people’s fingerprints has been given a share of a £39million healthcare grant.

To send a link to this page to a friend, you must be logged in.

Intelligent Fingerprinting, a spin-out from the University of East Anglia and a finalist in the Eastern Daily Press Business Awards, has received £425,000 to improve drug screening services in hospital A&E and coroners’ departments.

The money will help the company, which is also in the EDP’s Future 50, develop a test which analyses the minute amounts of sweat in a fingerprint to reveal whether an individual has taken drugs.

Administered through a handheld device and delivering results in 10 minutes, the test could have a range of applications – from working out if hospital patients have taken drugs and screening drivers at the roadside, to testing that employees are fit to work and working out causes of death.

David Willets, the minister for science and universities, announced the investment yesterday as part of a boost by the Biomedical Catalyst, a programme of public funding delivered by the Medical Research Council and the Technology Strategy Board to boost growth in the life sciences sector.

A project in partnership with the University of Leicester has been awarded £135,000 to research the technology’s use for fast and non-invasive drug screening of hospital A&E patients, reducing costs and improving care.

Dr Paul Yates, business development manager for Intelligent Fingerprinting, said understanding what drugs a patient had taken – whether medicines or illegal drugs – was crucial in emergency situations, in particular when patients are elderly, confused or unable to speak.

“Our technique for detecting the presence of drugs in a person’s bloodstream by analysing a simple fingerprint could help doctors to make better informed decisions about appropriate treatments,” he said.

A second award, for £290,000, will fund a study in conjunction with coroners to trial non-invasive drug testing of the deceased.

Dr Yates said: “It is sometimes necessary to carry out a drug screen to establish how someone has died. This can be a time-consuming and costly process.

“By working with coroners, we will test the potential of using Intelligent FingerprintingTM as a tool to help determine a possible cause of death more quickly and cost effectively.”

Intelligent Fingerprinting was one of 32 projects to receive a share of £39 million in funding from the government-backed Biomedical Catalyst. The awards were made to aid the development of innovative solutions to healthcare challenges.

3 comments

  • this is an unjust intrusion into peoples privacy.

    Report this comment

    clive hill

    Monday, November 5, 2012

  • just another way that you can be spyed on, even though there are people that can't afford to eat, money is being wasted on this already existing technology, this is a blatant big brother scam, is there anyone stupid enough to be taken in by this?

    Report this comment

    clive hill

    Monday, November 5, 2012

  • ** " working out if hospital patients have taken drugs and screening drivers at the roadside," ** Calm down Clive....explain to me why drivers involved in a crash or driving dangerously should not have this test applied to them . Do you also regard the breathalyser as a " an unjust intrusion into peoples privacy ".

    Report this comment

    LARSON.E. WHIPSNADE

    Tuesday, November 6, 2012

The views expressed in the above comments do not necessarily reflect the views of this site

ADVERTISEMENT

ADVERTISEMENT

Most read business stories

The proposed Morston Point business and leisure park site at King's Lynn

Failure to secure funding sees administrators appointed at Morston Assets Ltd

Question marks surround the fate of several development projects in and around King’s Lynn after the developers behind the project went into administration.

Read full story »

loading...

ADVERTISEMENT

ADVERTISEMENT